These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30618445)

  • 1. Comparison of the effectiveness of two-dose
    Igboeli NU; Adibe MO; Ukwe CV; Aguwa CN
    J Vector Borne Dis; 2018; 55(3):197-202. PubMed ID: 30618445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mefloquine for preventing malaria in pregnant women.
    González R; Pons-Duran C; Piqueras M; Aponte JJ; Ter Kuile FO; Menéndez C
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011444. PubMed ID: 29561063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact on pregnancy outcomes of intermittent preventive treatment with sulfadoxine-pyrimethamine in urban and peri-urban Papua New Guinea: a retrospective cohort study.
    Cellich P; Unger HW; Rogerson SJ; Mola GDL
    Malar J; 2024 Jul; 23(1):201. PubMed ID: 38970076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse birth outcomes among mothers who received intermittent preventive treatment with Sulphadoxine-Pyrimethamine in the low malaria transmission region.
    Mikomangwa WP; Oms M; Aklillu E; Kamuhabwa AAR
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):236. PubMed ID: 31286878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial.
    Diakite OS; Kayentao K; Traoré BT; Djimde A; Traoré B; Diallo M; Ongoiba A; Doumtabé D; Doumbo S; Traoré MS; Dara A; Guindo O; Karim DM; Coulibaly S; Bougoudogo F; Ter Kuile FO; Danis M; Doumbo OK
    Clin Infect Dis; 2011 Aug; 53(3):215-23. PubMed ID: 21765069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania.
    Mpogoro FJ; Matovelo D; Dosani A; Ngallaba S; Mugono M; Mazigo HD
    Malar J; 2014 Nov; 13():455. PubMed ID: 25421496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermittent preventive treatment with sulphadoxine-pyrimethamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria.
    Falade CO; Yusuf BO; Fadero FF; Mokuolu OA; Hamer DH; Salako LA
    Malar J; 2007 Jul; 6():88. PubMed ID: 17617910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes.
    Valea I; Tinto H; Drabo MK; Huybregts L; Henry MC; Roberfroid D; Guiguemde RT; Kolsteren P; D'Alessandro U;
    Malar J; 2010 Nov; 9():324. PubMed ID: 24576068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.
    Sirima SB; Cotte AH; Konaté A; Moran AC; Asamoa K; Bougouma EC; Diarra A; Ouédraogo A; Parise ME; Newman RD
    Am J Trop Med Hyg; 2006 Aug; 75(2):205-11. PubMed ID: 16896120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal.
    Olliaro PL; Delenne H; Cisse M; Badiane M; Olliaro A; Vaillant M; Brasseur P
    Malar J; 2008 Nov; 7():234. PubMed ID: 18992140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease of microscopic Plasmodium falciparum infection prevalence during pregnancy following IPTp-SP implementation in urban cities of Gabon.
    Bouyou-Akotet MK; Mawili-Mboumba DP; Kendjo E; Moutandou Chiesa S; Tshibola Mbuyi ML; Tsoumbou-Bakana G; Zong J; Ambounda N; Kombila M
    Trans R Soc Trop Med Hyg; 2016 Jun; 110(6):333-42. PubMed ID: 27268713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
    Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.
    Mosha D; Chilongola J; Ndeserua R; Mwingira F; Genton B
    Trop Med Int Health; 2014 Sep; 19(9):1048-56. PubMed ID: 24965022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
    Filler SJ; Kazembe P; Thigpen M; Macheso A; Parise ME; Newman RD; Steketee RW; Hamel M
    J Infect Dis; 2006 Aug; 194(3):286-93. PubMed ID: 16826475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia.
    Mace KE; Chalwe V; Katalenich BL; Nambozi M; Mubikayi L; Mulele CK; Wiegand RE; Filler SJ; Kamuliwo M; Craig AS; Tan KR
    Malar J; 2015 Feb; 14():69. PubMed ID: 25890159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
    Hamer DH; Mwanakasale V; Macleod WB; Chalwe V; Mukwamataba D; Champo D; Mwananyanda L; Chilengi R; Mubikayi L; Mulele CK; Mulenga M; Thea DM; Gill CJ
    J Infect Dis; 2007 Dec; 196(11):1585-94. PubMed ID: 18008241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness and perception of the use of sulphadoxine-pyrimethamine in intermittent preventive treatment of malaria in pregnancy programme in Offinso district of Ashanti region, Ghana.
    Tutu EO; Lawson B; Browne E
    Malar J; 2011 Dec; 10():385. PubMed ID: 22206597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socio-demographic and regional disparities in utilization of intermittent preventive treatment for malaria in pregnancy - Nigeria demographic health survey 2013.
    Olugbade OT; Ilesanmi OS; Gubio AB; Ajayi I; Nguku PM; Ajumobi O
    Pan Afr Med J; 2019; 32(Suppl 1):13. PubMed ID: 30949287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for placental malaria and associated adverse pregnancy outcomes in Rufiji, Tanzania: a hospital based cross sectional study.
    Ndeserua R; Juma A; Mosha D; Chilongola J
    Afr Health Sci; 2015 Sep; 15(3):810-8. PubMed ID: 26957969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania.
    Mikomangwa WP; Minzi O; Mutagonda R; Baraka V; Mlugu EM; Aklillu E; Kamuhabwa AAR
    Malar J; 2020 Apr; 19(1):160. PubMed ID: 32306955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.